Medtronic
Executive Summary
Will distribute without charge Ciba-Geigy's Lioresal Injection (baclofen) under a Treatment IND sponsored by the device manufacturer. "The Pink Sheet" reported in its March 19 issue (T&G-10) that Ciba-Geigy would distribute the drug free for the Treatment IND, which will study the effectiveness of baclofen administered through Medtronic's SynchroMed implantable pump as a treatment for spinal spasticity. Physicians treating spinal spasticity patients who have failed on oral antispasmodics may contact Medtronic at 800-328-0810 or 612-572-5000 for information. FDA is requesting the sponsor to call each doctor involved in the SynchroMed/baclofen Treatment IND weekly to ascertain the status of all patients, because of the drug/device combination's limited previous use in patients, the agency noted in a March 20 statement.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.